Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Open-market sale Chief Medical Officer sold 6,001 shares at $6.92 ($41,554)
  2. 4 Open-market sale President and Head of R&D sold 10,169 shares at $6.92 ($70,387)
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 10-K Report Annual Report
  9. 8-K Event Results of operations
  10. 4 Grant or award Director acquired 8,541 shares (grant or award)
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 8-K Event Material agreement · Other events
  18. 424B5 Offering Prospectus
  19. 8-K Event Results of operations
  20. 424B5 Offering Prospectus

Page 12 of 32 · 631 filings